The interactions of caffeine with monoamine oxidase

Life Sciences

Volumn 93, Issue 7, 2013, Pages 283-287

  Petzer, Anél ^a   Pienaar, Anke ^a   Petzer, Jacobus P ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Caffeine; Competitive; Inhibition; Monoamine oxidase; Reversible

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CAFFEINE;

ANIMAL CELL; ARTICLE; CATALYSIS; CATALYST; DRUG BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; INSECT CELL; MOLECULAR INTERACTION; NONHUMAN;

CAFFEINE; COMPETITIVE; INHIBITION; MONOAMINE OXIDASE; REVERSIBLE;

ANIMALS; BINDING, COMPETITIVE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DIALYSIS; HUMANS; ISOENZYMES; KINETICS; MICROSOMES; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

GYMNOMYZA;

EID: 84881315781     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.06.020     Document Type: Article

References (25)

1. J.P. Boulenger, J. Patel, and P.J. Marangos Effects of caffeine and theophylline on adenosine and benzodiazepine receptors in human brain Neurosci Lett 30 1982 161 166
2. M. Da Prada, G. Zürcher, I. Wüthrich, and W.E. Haefely On tyramine, food, beverages and the reversible MAO inhibitor moclobemide J Neural Transm Suppl 26 1988 31 56
3. H.H. Fernandez, and J.J. Chen Monoamine oxidase-B inhibition in the treatment of Parkinson's disease Pharmacotherapy 27 2007 174S 185S
4. J.P. Finberg, J. Wang, K. Bankiewicz, J. Harvey-White, I.J. Kopin, and D.S. Goldstein Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey J Neural Transm Suppl 52 1998 279 285
5. B.B. Fredholm, M.P. Abbracchio, G. Burnstock, J.W. Daly, T.K. Harden, and K.A. Jacobson Nomenclature and classification of purinoceptors Pharmacol Rev 46 1994 143 156
6. B.B. Fredholm, K. Bättig, J. Holmén, A. Nehlig, and E.E. Zvartau Actions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol Rev 51 1999 83 133
7. B.B. Fredholm, P. Hedqvist, and L. Vernet Effect of theophylline and other drugs on rabbit renal cyclic nucleotide phosphodiesterase, 5'-nucleotidase and adenosine deaminase Biochem Pharmacol 27 1978 2845 2850
8. B.B. Fredholm, and E. Lindgren Inhibition of soluble 5'-nucleotidase from rat brain by different xanthine derivatives Biochem Pharmacol 32 1983 2832 2834
9. B.E. Garrett, and S.G. Holtzman Does adenosine receptor blockade mediate caffeine-induced rotational behavior? J Pharmacol Exp Ther 274 1995 207 214
10. M. Harfenist, D.J. Heuser, C.T. Joyner, J.F. Batchelor, and H.L. White Selective inhibitors of monoamine oxidase. 3. Structure-activity relationship of tricyclics bearing imidazoline, oxadiazole, or tetrazole groups J Med Chem 39 1996 1857 1863
11. Y.K. Lee, K.M. Ng, W.H. Lai, Y.C. Chan, Y.M. Lau, and Q. Lian Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes Stem Cell Rev 7 2011 976 986
12. C.I. Manley-King, J.J. Bergh, and J.P. Petzer Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues Bioorg Med Chem 19 2011 261 274
13. P.S. McPherson, Y.K. Kim, H. Valdivia, C.M. Knudson, H. Takekura, and C. Franzini-Armstrong The brain ryanodine receptor: a caffeine-sensitive calcium release channel Neuron 7 1991 17 25
14. A. Nehlig, J.L. Daval, and G. Debry Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects Brain Res Brain Res Rev 17 1992 139 170
15. L. Novaroli, M. Reist, E. Favre, A. Carotti, M. Catto, and P.A. Carrupt Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening Bioorg Med Chem 13 2005 6212 6217
16. A. Petzer, B.H. Harvey, G. Wegener, and J.P. Petzer Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase Toxicol Appl Pharmacol 258 2012 403 409
17. S.P. Potta, X. Sheng, J.A. Gaspar, K. Meganathan, S. Jagtap, and K. Pfannkuche Functional characterization and gene expression profiling of α-smooth muscle actin expressing cardiomyocytes derived from murine induced pluripotent stem cells Stem Cell Rev 8 2012 229 242
18. R.R. Ramsay, C. Dunford, and P.K. Gillman Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction Br J Pharmacol 152 2007 946 951
19. F.W. Smellie, C.W. Davis, J.W. Daly, and J.N. Wells Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity Life Sci 24 1979 2475 2482
20. S.C. Stanford, B.J. Stanford, and P.K. Gillman Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium J Psychopharmacol 24 2010 1433 1438
21. B. Strydom, J.J. Bergh, and J.P. Petzer The inhibition of monoamine oxidase by 8-(2-phenoxyethoxy)caffeine analogues Arzneimittelforschung 62 2012 513 518
22. B. Strydom, S.F. Malan, N. Castagnoli Jr., J.J. Bergh, and J.P. Petzer Inhibition of monoamine oxidase B by 8-benzyloxycaffeine analogues Bioorg Med Chem 18 2010 1018 1028
23. J. Tai, S. Cheung, E. Chan, and D. Hasman Antiproliferation effect of commercially brewed coffees on human ovarian cancer cells in vitro Nutr Cancer 62 2010 1044 1057
24. 2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC) Bioorg Med Chem 14 2006 3512 3521
25. M. Yamada, and H. Yasuhara Clinical pharmacology of MAO inhibitors: safety and future Neurotoxicology 25 2004 215 221